About
Working to connect the people and ideas that will advance the pharmaceutical, biotech…
Activity
-
Part 2 of my newest blog- Particle testing of sterile drugs and combination products.
Part 2 of my newest blog- Particle testing of sterile drugs and combination products.
Liked by Jon Howland
-
**Join Us for an Insightful Event on Novel Protein Therapeutics!** Are you involved in developing complex protein-based therapies like antibody-drug…
**Join Us for an Insightful Event on Novel Protein Therapeutics!** Are you involved in developing complex protein-based therapies like antibody-drug…
Liked by Jon Howland
Experience
Education
More activity by Jon
-
Often, a #CDMO partner is selected after a single recommendation or after being approached by a business development representative, but this choice…
Often, a #CDMO partner is selected after a single recommendation or after being approached by a business development representative, but this choice…
Liked by Jon Howland
-
Cell therapy manufacturing is a costly and manually intensive process that’s prone to error — but luckily, one that’s seeing a wave of innovation and…
Cell therapy manufacturing is a costly and manually intensive process that’s prone to error — but luckily, one that’s seeing a wave of innovation and…
Liked by Jon Howland
-
💬 Open lines of communication with the FDA — that's the difference maker, says Cybin Inc CEO Doug Drysdale, who recently sat down with Clinical…
💬 Open lines of communication with the FDA — that's the difference maker, says Cybin Inc CEO Doug Drysdale, who recently sat down with Clinical…
Liked by Jon Howland
-
How many impressions does it take to get a prospect to engage with your brand? It used to be a handful. Now that number is exponentially higher…
How many impressions does it take to get a prospect to engage with your brand? It used to be a handful. Now that number is exponentially higher…
Liked by Jon Howland
-
Just accept that you're going to get a 483. That's what Vincent F. Cafiso says he tells his clients as they prepare for an #FDA inspection. Check out…
Just accept that you're going to get a 483. That's what Vincent F. Cafiso says he tells his clients as they prepare for an #FDA inspection. Check out…
Liked by Jon Howland
-
The proposed move by the USPTO to tie patent validity together based on the filing of terminal disclaimers is one that would have a significant…
The proposed move by the USPTO to tie patent validity together based on the filing of terminal disclaimers is one that would have a significant…
Liked by Jon Howland
-
Are you registered for the Bio-Expo Live: Upstream Bioprocessing Event taking place tomorrow, Tuesday July 30th starting at 10am eastern…
Are you registered for the Bio-Expo Live: Upstream Bioprocessing Event taking place tomorrow, Tuesday July 30th starting at 10am eastern…
Liked by Jon Howland
-
Last week, my colleague Matthew Pillar and I sat down to record another #BusinessOfBiotech episode with the dream team behind Radar Therapeutics,…
Last week, my colleague Matthew Pillar and I sat down to record another #BusinessOfBiotech episode with the dream team behind Radar Therapeutics,…
Liked by Jon Howland
-
mRNA Delivering Full-length Dystrophin for DMD https://lnkd.in/ehtqNStd Developing an mRNA Therapy for DMD with Elixirgen Therapeutics, Inc.'s Aki Ko
mRNA Delivering Full-length Dystrophin for DMD https://lnkd.in/ehtqNStd Developing an mRNA Therapy for DMD with Elixirgen Therapeutics, Inc.'s Aki Ko
Liked by Jon Howland
-
Looking for a partner in cell & gene therapy development and manufacturing with available capacity? Today's expo is a great chance to check out the…
Looking for a partner in cell & gene therapy development and manufacturing with available capacity? Today's expo is a great chance to check out the…
Liked by Jon Howland
-
Join Outsourced Pharma today at 2 p.m. for an informative session on how you can expand your CDMO options when it comes to your small molecule…
Join Outsourced Pharma today at 2 p.m. for an informative session on how you can expand your CDMO options when it comes to your small molecule…
Liked by Jon Howland
-
Join Shruti Iyer and Charles Curran at Clinical Leader's Patient Recruitment and Retention Solutions Expo to learn how Oracle Life Sciences can help…
Join Shruti Iyer and Charles Curran at Clinical Leader's Patient Recruitment and Retention Solutions Expo to learn how Oracle Life Sciences can help…
Liked by Jon Howland
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Jon Howland in United States
35 others named Jon Howland in United States are on LinkedIn
See others named Jon Howland